Stimuli-responsive and cellular targeted nanoplatforms for multimodal therapy of skin cancer

Bharath Singh Padya, Abhijeet Pandey, Muralidhar Pisay, K. B. Koteshwara, Raghu Chandrashekhar Hariharapura, Kuruveri Udaya Bhat, Swati Biswas, Srinivas Mutalik

Research output: Contribution to journalReview articlepeer-review

Abstract

Interdisciplinary applications of nanopharmaceutical sciences have tremendous potential for enhancing pharmacokinetics, efficacy and safety of cancer therapy. The limitations of conventional therapeutic platforms used for skin cancer therapy have been largely overcome by the use of nanoplatforms. This review discusses various nanotechnological approaches experimented for the treatment of skin cancer. The review describes various polymeric, lipidic and inorganic nanoplatforms for efficient therapy of skin cancer. The stimuli-responsive nanoplatforms such as pH-responsive as well as temperature-responsive platforms have also been reviewed. Different strategies for potentiating the nanoparticles application for cancer therapy such as surface engineering, conjugation with drugs, stimulus-responsive and multimodal effect have also been discussed and compared with the available conventional treatments. Although, nanopharmaceuticals face challenges such as toxicity, cost and scale-up, efforts put-in to improve these drawbacks with continuous research would deliver exciting and promising results in coming days.

Original languageEnglish
Article number173633
JournalEuropean Journal of Pharmacology
DOIs
Publication statusAccepted/In press - 2020

All Science Journal Classification (ASJC) codes

  • Pharmacology

Fingerprint Dive into the research topics of 'Stimuli-responsive and cellular targeted nanoplatforms for multimodal therapy of skin cancer'. Together they form a unique fingerprint.

Cite this